Role of oxidative stress in high glucose-induced decreased expression of Giα proteins and adenylyl cyclase signaling in vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 6, 2008, Pages

  Li, Yuan ^a   Descorbeth, Magda ^a   Anand Srivastava, Madhu B ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Antioxidants; G proteins; Inhibitory guanine nucleotide regulatory protein

Indexed keywords

ADENYLATE CYCLASE; ANTIOXIDANT; DIPHENYLIODONIUM SALT; FORSKOLIN; GLUCOSE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; N(G) NITROARGININE METHYL ESTER; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; URIC ACID; ENZYME ACTIVATOR; ENZYME INHIBITOR; GNAI2 PROTEIN, RAT; GNAI3 PROTEIN, RAT; HORMONE; NITRIC OXIDE SYNTHASE; PEROXYNITROUS ACID; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERGLYCEMIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; VASCULAR SMOOTH MUSCLE; ANIMAL; BLOOD; CELL CULTURE; CELL LINE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT;

ADENYLATE CYCLASE; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CELL LINE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; ENZYME ACTIVATORS; ENZYME INHIBITORS; GLUCOSE; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HORMONES; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PEROXYNITROUS ACID; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SUPEROXIDES;

EID: 49249090436     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.91422.2007     Document Type: Article

References (56)

1. Anand-Srivastava MB, de Champlain J, Thibault C. DOCA-salt hypertensive rat hearts exhibit altered expression of G-proteins. Am J Hypertens 6: 72-75, 1993.
2. Anand-Srivastava MB, Srivastava AK, Cantin M. Pertussis toxin attenuates atrial natriuretic factor-mediated inhibition of adenylyl cyclase. Involvement of inhibitory guanine nucleotide regulatory protein. Biochem J 262: 4931-4934, 1987.
3. Anand-Srivastava MB. Enhanced expression of inhibitory guanine nucleotide regulatory protein in spontaneously hypertensive rats: relationship to adenylate cyclase inhibition. Biochem J 288: 79-85, 1992.
4. Anand-Srivastava MB. Angiotensin II receptors are negatively coupled to adenylyl cyclase in rat myocardial sarcolemma. Involvement of inhibitory guanine nucleotide regulatory protein. Biochem Pharmacol 38: 489-496, 1989.
5. Anand-Srivastava MB. Angiotensin II receptors are negatively coupled to adenylyl cyclase in rat aorta. Biochem Biophys Res Commun 117: 420-428, 1983.
6. Anand-Srivastava MB, Franks DJ, Cantin M, Genest J. Presence of "Ra" and "P"-site receptors for adenosine coupled to adenylate cyclase in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 108: 213-219, 1982.
7. i-protein expression and adenylyl cyclase signaling in vascular smooth muscle cells. Free Radic Biol Med 7: 1162-1173, 2006.
8. i protein and adenylyl cyclase activity in vascular smooth muscle cells. Cell Biochem Biophys 47: 99-108, 2007.
9. iα protein and adenylyl cyclase signaling in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 294: H775-H784, 2008.
10. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9, 1999.
11. Bohlen JM, Nase GP. Arteriolar nitric oxide concentration is decreased during hyperglycemia-induced βII PKC activation. Am J Physiol Heart Circ Physiol 280: H621-H627, 2001.
12. sα signal transduction protein. Proc Natl Acad Sci USA 83: 8893-8897, 1986.
13. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 14: 813-820, 2001.
14. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidative stress. Circ Res 87: 840-844, 2000.
15. Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 44: 834-838, 2001.
16. Cowell JA. Vascular thrombosis in type II diabetes mellitus. Diabetes 32: 8-11, 1993.
17. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoute PM. Endothelial dysfunction in diabetes. Br J Pharmacol 130: 963-974, 2000.
18. Descorbeth M, Anand-Srivastava MB. High glucose augmented Gαq-mediated cell signaling in vascular smooth muscle cells (VSMC): role of oxidative stress (Abstract). FASEB J 20: A664, 2006.
19. Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, Van Dop C. Increase of the 40,000 mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest 82: 189-197, 1988.
20. Fleming JW, Wisler PL, Watanbe AM. Signal transduction by G-proteins in cardiac tissues. Circulation 85: 420-433, 1992.
21. i activity in diabetes. Nature 327: 229-232, 1987.
22. Giugliano D, Marfella R, Coppola L, Verazzo G, Acampora R, Giunta R, Nappo F, Lucarelli C, D'Onofrio F. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 95: 1783-1790, 1997.
23. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267, 1996.
24. Hargrove GM, Dufresne J, Whiteside C, Muruve DA, Wong NC. Diabetes mellitus increases endothelin-1 gene transcription in rat kidney. Kidney Int 58: 1534-1545, 2000.
25. Hashim S, Li Y, Nagakura A, Takeo S, Anand-Srivastava MB. Modulation of G-protein expression and adenylyl cyclase signaling by high glucose in vascular smooth muscle. Cardiovasc Res 63: 709-718, 2004.
26. Hashim S, Liu YY, Wang R, Anand-Srivastava MB. Streptozotocin-induced diabetes impairs G-protein linked signal transduction in vascular smooth muscle. Mol Cell Biochem 240: 57-65, 2002.
27. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945, 2000.
28. Inoguchi T, Nawata H. NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome. Curr Drug Targets 6: 495-501, 2005.
29. Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H, Utsumi H, Nawata H. Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol 14, Suppl 3: S227-S232, 2003.
30. i protein: a subunit structure of rat cDNA and human genomic DNAs. J Biol Chem 263: 6656-6664, 1988.
31. Kimes BW, Brandt BL. Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res 98: 349-366, 1976.
32. Kostenis E, Zeng FY, Wess J. Structure-function analysis of muscarinic receptors and their associated G proteins. Life Sci 64: 355-362, 1999.
33. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866, 1998.
34. Kunisaki M, Hursell SE, Umeda F, Nawata H, King G. Normalization of diacyglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43: 1372-1377, 1997.
35. iα protein and adenylyl cyclase signaling in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 23: 2251-2261, 2005.
36. Lash JM, Nase GP, Bohlen HG. Acute hyperglycemia depresses arteriolar NO formation in skeletal muscle. Am J Physiol Heart Circ Physiol 277: H1513-H1520, 1999.
37. iα proteins and adenylyl cyclase signaling in A10 vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 292: H1922-H1930, 2007.
38. Liu S, Ma X, Gong M, Shi L, Lincoln T, Wang S. Glucose downregulation of cGMP-dependent protein kinase I expression in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species. Free Radic Biol Med 42: 852-863, 2007.
39. i alpha 2. Nature 379: 840-844, 1996.
40. Neer EJ. Heterotrimeric G proteins. Organizers of transmembrane signals. Cell 80: 249-257, 1995.
41. Nishikawa T, Edelstein D, Dux L, Yamagishi SI, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Gilardino I, Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
42. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 61: 186-194, 2002.
43. Pacher P, Liaudet I, Garcia Sorjano F, Mabley JG, Szabo E, Szabo C. The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51: 514-521, 2002.
44. Pacher P, Obrosova IG, Mabley JG, Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 12: 267-275, 2005.
45. Palmer GC, Wilson GL, Chronister RB. Streptozotocin-induced diabetes produces alterations in adenylate cyclase in rat cerebrum, cerebral microvessels and retina. Life Sci 24: 365-374, 1983.
46. Park JY, Takahara N, Gabriele A, Chou E, Naruse K, Suzuma K, Yamauchi T, Ha SW, Meier M, Rhodes CJ, King GL. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes 49: 1239-1248, 2000.
47. Pennathur S, Wagner JD, Leeuwenburgh C, Litwak KN, Heinecke JW. A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. J Clin Invest 107: 853-860, 2001.
48. Rajesh M, Mukhopadhyay P, Batkai S, Hasko G, Liaudet L, Drel VR, Obrusova IG, Packer P. Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. Am J Physiol Heart Circ Physiol 293: H610-H619, 2007.
49. Sodhi CP, Kanwar YS, Sahai A. Hypoxia and high glucose upregulate AT1 receptor expression and potentiate ANG II-induced proliferation in VSM cells. Am J Physiol Heart Circ Physiol 284: H846-H852, 2003.
50. Spitaler MM, Graier WF. Vascular targets of redox signaling in diabetes mellitus. Diabetologia 45: 476-494, 2002.
51. i) on adipocyte adenylate cyclase activity. Biochem J 266: 521-526, 1990.
52. Tannous M, Rabini RA, Vignini A, Moretti N, Fumelli P, Zielinski B, Mazzanti L, Mutus B. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia 42: 539-544, 1999.
53. Touyz RM, Yao G, Viel E, Amiri F, Schiffrin EL. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J Hypertens 22: 1141-1149, 2004.
54. i-mediated hormonal inhibition of cyclic AMP accumulation. Science 255: 339-342, 1992.
55. iα subunits. Nature 336: 680-682, 1988.
56. ialpha2 in vivo ameliorates streptozotocin-induced diabetes. J Biol Chem 273: 23649-23651, 1998.